Wed, Jul 23, 2014, 6:17 AM EDT - U.S. Markets open in 3 hrs 13 mins


% | $
Click the to save as a favorite.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • devistator011 devistator011 Aug 31, 2005 6:26 PM Flag

    This company is a total disaster

    Medinol will probably win $4 million against BSX, that could hurt. J&J also won a lawsuit against us, and our stents were voted inferior products and rejected by doctors.
    UPDATE 1-Journal studies tip scales in favor of J&J stent
    Tue Aug 16, 2005 05:37 PM ET
    (Adds comments from companies, physician)
    By Gene Emery and Julie Steenhuysen

    BOSTON/CHICAGO, Aug 16 (Reuters) - Studies in two major medical journals released on Tuesday suggest that Johnson & Johnson's(JNJ.N: Quote, Profile, Research) heart stent works better than a rival device by Boston Scientific Corp. (BSX.N: Quote, Profile, Research) at keeping blood flowing through diseased heart arteries.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You are a little off on what BSX will owe Medinol. Medinol has already turned down a settlement offer of $750 million from BSX (BSX admitting their guilt in breach of contract)! It is going back to court on 9/19 and Medinol could win as much as $1.5-2 BILLION!!

12.85+0.30(+2.39%)Jul 22 4:01 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.